Status:
COMPLETED
The Effects of Short Message Notifications on Middle-Aged Diabetic Patients
Lead Sponsor:
Istanbul University
Conditions:
Type2 Diabetes Mellitus
Eligibility:
All Genders
40-64 years
Phase:
NA
Brief Summary
The objective of our study was to assess awareness-raising of medication adherence (MA), physical activity (PA), fasting blood glucose (FBG), and glycated hemoglobin A (HbA1c) values by providing info...
Detailed Description
The study investigates T2DM patients who have not had surgery or cardiac event in the last 3 months, between the ages of 40 and 64 years, with T2DM diagnosis between the last 1 and 10 years and oral a...
Eligibility Criteria
Inclusion
- Clinical diagnosis of Type 2 Diabetes Mellitus (T2DM) between the last 1 and 10 years
- Being aged between 40 and 64 years old,
- Is treated for a minimum of 1 year with at least one oral antidiabetic drug.
Exclusion
- Clinical diagnosis of T2DM for less than 1 year or more than 10 years.
- Those who have had surgery or a cardiac event in the last 3 months or during the investigation.
- Those under 40 and over 64 years of age.
- Patients with T2DM that have not been treated with oral antidiabetic medication.
- Volunteers who once did not participate in the control examinations in both groups were excluded from the evaluation.
Key Trial Info
Start Date :
June 30 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 26 2018
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT04733612
Start Date
June 30 2016
End Date
February 26 2018
Last Update
February 2 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.